Immune Science

Canadian COVID-19 Prospective Cohort Study (CANCOV)

Angela Cheung and Margaret Herridge, University Health Network

The Canadian COVID-19 Prospective Cohort Study (CANCOV) aims to provide a comprehensive evaluation of early to one-year outcomes in 2,000 patients with COVID-19 infection and 500 family caregivers from the four hardest-hit provinces in Canada: Quebec, Ontario, Alberta, and British Columbia.
Research summary Study website

Understanding immunity against SARS-CoV-2

Michael Grant, Memorial Universty of Newfoundland

This study systematically assesses the strength, specificity, nature, and durability of antibody and cellular immune responses generated against SARS-CoV-2 in relation to severity of infection — in previously infected individuals.
Research summary

Predicting sustained SARS-CoV-2 antibody responses after COVID-19 infection

Daniel Kaufmann and Andrés Finzi, Centre hospitalier de l’Universite de Montreal

This study focuses on early clinical and immunological features of COVID-19 that can predict the emergence of protective and durable immune responses.
Research summary Results

COVID-19 infection, antibody responses, and immunity in at-risk individuals

Marc-André Langlois, University of Ottawa

Researchers will follow 500 healthy, at-risk individuals and 500 individuals who have previously tested positive for the virus or have received a vaccine to determine how much protection antibodies provide against repeat exposure to the virus and how long this protection, as well as the immunity provided by vaccines, will last.
Research summary Results

Determining long-term immune protection in COVID-19 patients

Ishac Nazy, McMaster University

This study aims to identify how the immune system responds to SARS-CoV-2 by examining different elements of the immune response, including antibodies and T cells that attack the virus, as well as immune memory B and T cells responsible for long-term protection from the virus.
Research summary Results View study on

Can COVID-19 and maternal antibodies to SARS-CoV-2 be transmitted through human milk?

Deborah O’Connor and Sharon Unger, Sinai Health / University of Toronto

This study aims to determine the SARS-CoV-2 transmissibility in human milk, measure associated antibodies, and examine the impact of thermal pasteurization on SARS-CoV-2 infectivity.
Research summary

Towards a better understanding of immunity to SARS-CoV-2

Tania Watts and Mario Ostrowski, University of Toronto

The study aims to understand the immune responses to SARS-CoV-2 and how these responses might explain a good or a bad outcome. This information will be important for designing vaccines, monitoring individuals for the correct immune responses, and evaluating how people who have had COVID-19 will respond to vaccines.
Research summary Results

Optimization of Immunological Testing Studies

Rational design and standardization of COVID-19 antibody tests

Andrei Drabovich, University of Alberta

The study targets the research area of sero-surveillance testing for COVID-19 infection, with the goal of improving serology testing through the rational design and standardization of assays.
Research summary

A rapid testing device for SARS-CoV-2 neutralizing antibodies

Dustin Little, Ryerson University

This project’s goal is to develop a fast and cost-effective method to detect neutralizing antibodies (nAbs) for SARS-CoV-2, with reduced biosafety requirements for immediate distribution.
Research summary

When antibodies don’t protect you against a virus

Ryan Troyer, University of Western Ontario

The goal of this study is to develop a test that can screen human serum to detect antibodies that enhance SARS-CoV-2, the virus that causes COVID-19.
Research summary

See our other funded reseach studies

See our other funded reseach studies